- Home
- PHUN vs ANIX Comparison
PHUN vs ANIX Comparison
Compare PHUN & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- ANIX
- Stock Information
- Founded
- PHUN 2009
- ANIX 1982
- Country
- PHUN United States
- ANIX United States
- Employees
- PHUN N/A
- ANIX N/A
- Industry
- PHUN EDP Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- PHUN Technology
- ANIX Health Care
- Exchange
- PHUN Nasdaq
- ANIX Nasdaq
- Market Cap
- PHUN 64.1M
- ANIX 88.9M
- IPO Year
- PHUN N/A
- ANIX 1987
- Fundamental
- Price
- PHUN $3.20
- ANIX $3.26
- Analyst Decision
- PHUN Buy
- ANIX Strong Buy
- Analyst Count
- PHUN 2
- ANIX 3
- Target Price
- PHUN $7.75
- ANIX $9.00
- AVG Volume (30 Days)
- PHUN 330.6K
- ANIX 254.0K
- Earning Date
- PHUN 08-07-2025
- ANIX 05-28-2025
- Dividend Yield
- PHUN N/A
- ANIX N/A
- EPS Growth
- PHUN N/A
- ANIX N/A
- EPS
- PHUN N/A
- ANIX N/A
- Revenue
- PHUN $2,956,000.00
- ANIX N/A
- Revenue This Year
- PHUN $3.01
- ANIX N/A
- Revenue Next Year
- PHUN $50.72
- ANIX N/A
- P/E Ratio
- PHUN N/A
- ANIX N/A
- Revenue Growth
- PHUN N/A
- ANIX N/A
- 52 Week Low
- PHUN $2.22
- ANIX $2.07
- 52 Week High
- PHUN $14.60
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- PHUN 50.62
- ANIX 51.51
- Support Level
- PHUN $2.95
- ANIX $3.15
- Resistance Level
- PHUN $3.10
- ANIX $3.52
- Average True Range (ATR)
- PHUN 0.22
- ANIX 0.26
- MACD
- PHUN -0.02
- ANIX -0.03
- Stochastic Oscillator
- PHUN 24.27
- ANIX 10.77
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.